Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Latest Information Update: 16 Apr 2024
At a glance
- Drugs Infliximab biobetter (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 09 Apr 2024 Status changed from not yet recruiting to recruiting.
- 22 Jun 2023 Route assumed from RDI.
- 22 Jun 2023 New trial record